Literature DB >> 21781369

Modelling meningococcal meningitis in the African meningitis belt.

T J Irving1, K B Blyuss, C Colijn, C L Trotter.   

Abstract

SUMMARYMeningococcal meningitis is a major public health problem in a large area of sub-Saharan Africa known as the meningitis belt. Disease incidence increases every dry season, before dying out with the first rains of the year. Large epidemics, which can kill tens of thousands of people, occur frequently but unpredictably every 6-14 years. It has been suggested that these patterns may be attributable to complex interactions between the bacteria, human hosts and the environment. We used deterministic compartmental models to investigate how well simple model structures with seasonal forcing were able to qualitatively capture these patterns of disease. We showed that the complex and irregular timing of epidemics could be caused by the interaction of temporary immunity conferred by carriage of the bacteria together with seasonal changes in the transmissibility of infection. This suggests that population immunity is an important factor to include in models attempting to predict meningitis epidemics.

Entities:  

Mesh:

Year:  2011        PMID: 21781369     DOI: 10.1017/S0950268811001385

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

1.  Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012.

Authors:  Emma C Wall; Dean B Everett; Mavuto Mukaka; Naor Bar-Zeev; Nicholas Feasey; Andreas Jahn; Mike Moore; Joep J van Oosterhout; Paul Pensalo; Kenneth Baguimira; Stephen B Gordon; Elizabeth M Molyneux; Enitan D Carrol; Neil French; Malcolm E Molyneux; Robert S Heyderman
Journal:  Clin Infect Dis       Date:  2014-02-04       Impact factor: 9.079

2.  A periodic disease transmission model with asymptomatic carriage and latency periods.

Authors:  Isam Al-Darabsah; Yuan Yuan
Journal:  J Math Biol       Date:  2017-12-22       Impact factor: 2.259

3.  Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study.

Authors:  S M Niaz Arifin; Christoph Zimmer; Caroline Trotter; Anaïs Colombini; Fati Sidikou; F Marc LaForce; Ted Cohen; Reza Yaesoubi
Journal:  Med Decis Making       Date:  2019-07-03       Impact factor: 2.583

4.  Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls.

Authors:  Ottavia Prunas; Daniel M Weinberger; Duccio Medini; Michele Tizzoni; Lorenzo Argante
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 4.897

5.  Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Authors:  L Agier; A Deroubaix; N Martiny; P Yaka; A Djibo; H Broutin
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

6.  Analysing spatio-temporal clustering of meningococcal meningitis outbreaks in Niger reveals opportunities for improved disease control.

Authors:  Juliette Paireau; Florian Girond; Jean-Marc Collard; Halima B Maïnassara; Jean-François Jusot
Journal:  PLoS Negl Trop Dis       Date:  2012-03-20

7.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

8.  Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.

Authors:  Katy Am Gaythorpe; Kaja Abbas; John Huber; Andromachi Karachaliou; Niket Thakkar; Matthew Ferrari; Michael L Jackson; Kevin McCarthy; T Alex Perkins; Caroline Trotter; Mark Jit; Kim Woodruff; Xiang Li; Susy Echeverria-Londono
Journal:  Elife       Date:  2021-06-24       Impact factor: 8.140

9.  Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.

Authors:  Sara Tartof; Amanda Cohn; Félix Tarbangdo; Mamoudou H Djingarey; Nancy Messonnier; Thomas A Clark; Jean Ludovic Kambou; Ryan Novak; Fabien V K Diomandé; Isaïe Medah; Michael L Jackson
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

10.  Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.

Authors:  Caroline L Trotter; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Sita S Kroman; Regina S Idohou; Oumarou Sanou; Leah Bowen; Helen Findlow; Serge Diagbouga; Bradford D Gessner; Ray Borrow; Judith E Mueller
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.